How Much Did Minnesota Pathologists Chartered Raise?
Funding & Key Investors

Minnesota Pathologists Chartered has successfully secured a significant capital injection, bringing its total cumulative financing to $335K. This latest infusion of capital, totaling $185K, underscores the firm's robust position within the regional healthcare diagnostic sector. By leveraging this strategic investment, the organization continues to solidify its operational footprint, ensuring that its specialized pathology services remain at the forefront of clinical excellence in West Central Minnesota.

What is Minnesota Pathologists Chartered?

Minnesota Pathologists Chartered
Hospitals & Physicians ClinicsPhysicians ClinicsHealthcare Services

Minnesota Pathologists Chartered (MPC) operates as a specialized medical practice providing essential pathology services to healthcare institutions, most notably CentraCare - Rice Memorial Hospital. The firm functions as a critical node in the regional medical infrastructure, offering high-quality, cost-effective diagnostic support that is vital for patient outcomes. By maintaining a team of highly skilled pathologists, MPC bridges the gap between complex laboratory analysis and frontline clinical care, ensuring that healthcare providers have access to reliable, timely, and accurate diagnostic data. Their market position is defined by a commitment to operational efficiency and a deep integration into the local healthcare ecosystem, which serves as a cornerstone for their sustained service delivery model.

How much funding has Minnesota Pathologists Chartered raised?

Minnesota Pathologists Chartered has raised a total of $335K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$185K

Debt (2020): $150K with participation from PPP

Debt (2021): $185K led by PPP

Key Investors in Minnesota Pathologists Chartered

PPP

Public-Private Partnership

What's next for Minnesota Pathologists Chartered?

With the successful completion of this late-stage financing, Minnesota Pathologists Chartered is well-positioned to scale its diagnostic capabilities and enhance its service delivery framework. The strategic allocation of these funds will likely focus on optimizing laboratory workflows, integrating advanced diagnostic technologies, and expanding the reach of their pathology support services to meet the growing demands of the West Central Minnesota healthcare market. As the firm transitions into this next phase of growth, the focus remains on maintaining the high standards of clinical accuracy that have defined their practice, while simultaneously exploring opportunities to modernize their diagnostic infrastructure to better serve the evolving needs of their hospital partners and the broader patient population.

See full Minnesota Pathologists Chartered company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice ManagementHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsMedical & Surgical HospitalsHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsMedical & Surgical HospitalsPhysicians Clinics
Hospitals & Physicians ClinicsMedical & Surgical HospitalsMedical Practice Management

Frequently Asked Questions Regarding Minnesota Pathologists Chartered Financial Insights

What are the most recent funding rounds that Minnesota Pathologists Chartered has completed, and what were the funding rounds?
Minnesota Pathologists Chartered has recently completed 2 funding rounds: Debt on Feb 6, 2021, Debt on Apr 9, 2020.
What is the total amount of funding Minnesota Pathologists Chartered has raised to date?
Minnesota Pathologists Chartered has raised a total of $335K in funding to date.
How many funding rounds has Minnesota Pathologists Chartered completed?
Minnesota Pathologists Chartered has completed 2 funding rounds.
How much funding did Minnesota Pathologists Chartered raise in its most recent funding round?
Minnesota Pathologists Chartered raised $185K in its most recent funding round.
Who are the lead investors in Minnesota Pathologists Chartered's latest funding round?
The lead investor in Minnesota Pathologists Chartered's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Minnesota Pathologists Chartered's history?
The largest funding round in Minnesota Pathologists Chartered's history was $185K.
See more information about Minnesota Pathologists Chartered